Author:
Deshmukh Smeet,Ogunyankin Maria O.
Publisher
Springer International Publishing
Reference65 articles.
1. Wang W, Singh S, Zeng DL, King K, Nema S. Antibody structure, instability, and formulation. J Pharm Sci. 2007;96(1):1–26.
2. Food and Drug Administration. Lists of licensed biological products with reference product exclusivity and biosimilarity or interchangeability evaluations. In Purple Book 2019; 2019.
3. Conner J, Wuchterl D, Lopez M, Minshall B, Prusti R, Boclair D, Peterson J, Allen C. Chapter 26; The Biomanufacturing of Biotechnology Products. In: Craig Shimasaki, editor. Biotechnology Entrepreneurship. 1st ed. Elsevier, Inc., Oxford, UK. 2014;351–385
4. Harris RJ, Shire SJ, Winter C. Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies. Drug Dev Res. 2004;61:137–54.
5. Wang W. Instability, stabilization and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185:125–88.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献